Trial
NCT03947814
A Study of Orally Administered Pimodivir in Adult Participants With Renal Impairment
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Janssen-Cilag International NV
Collaborators
—
Condition
Kidney Failure, Chronic
Intervention
Pimodivir
Why stopped
Study 63623872FLZ1014 was terminated early based on a strategic business decision by Janssen to end the clinical development program of JNJ-63623872.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-02-03